Consistent overexpression of ITGAV across multiple independent datasets, and its correlation with poor patient survival in TCGA‐PAAD, suggest that ITGAV expression is a putative biomarker for a more aggressive PDAC phenotype. The gene discussed is ITGAV; the disease is pancreatic adenocarcinoma.